Mankind Pharma reports Q2 and H1 FY27 financial results
Mankind Pharma reports Q2 and H1 FY27 financial results released on October 26, 2026. The company disclosed its standalone and consolidated financial performance for the quarter and half-year ending September 30, 2026. Key metrics include revenue of ₹1,240 crore and net profit of ₹182 crore for Q2, showing 14% YoY growth in profits.
📊 STOCKS: $MANKIND | 🏢 SECTOR: Pharma | #HIGHIMPACT #earnings
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.